- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05352009
The Application of Sling Exercise Training in People With Chronic Stroke
The Application of Sling Exercise Training in People With Chronic Stroke - The Emphasis of Core Muscle Control on Gait
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background and purpose: Balance and gait performance are often impaired in people post stroke. Evidence showed positive correlations between trunk control and balance and walking ability. Previous studies applying core muscle training reported positive effects on improving trunk control and sitting balance among patients with chronic stroke, but benefits on standing balance and gait performance remain undetermined. Sling exercise training (SET) has been suggested for improving core muscle stability and strength in people with stroke. However, studies about effects of SET on gait performance in stroke populations are limited. Therefore, the present study aims to investigate the effects of SET for core muscle on gait performance in people with chronic stroke.
Methods: Thirty-eight individuals with chronic stroke will be recruited and assigned to one of the two groups by randomization, sling exercise training group and conventional training group. The training is 30 minutes per session, 3 sessions per week for total of 4 weeks. Gait performance is the primary outcome to include gait speed, stride length, single leg support time and temporal and spatial symmetry measured by GAITRite® System. Secondary outcomes include balance, timed up-and-go (TUG) test and trunk performance. All outcomes will be assessed before, after the 4-week training program and at 4-week follow-up.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ray-Yau Wang, PhD
- Phone Number: +886-2-2826-7210
- Email: rywang@nycu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 112
- National Yang Ming Chiao Tung University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Stroke after onset ≥ 6 months
- Trunk impairment scale (TIS) score ≤ 21 at baseline
- Brunnstrome stage ≥ IV over the affected lower extremity
- Ability to independently walk for 10 meters with or without assistive devices
- Intact cognition with mini-mental state examination (MMSE) ≥ 24
Exclusion Criteria:
- Any other significant musculoskeletal disorder, neurological disease or cardiovascular disease that may affect the participation in this study.
- Vision or language deficit that may affect participating in this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sling exercise training group
Participants will practice core muscle exercise in different positions with sling systems (Redcord®, Norway).
|
All participants will receive exercise training for 30 min/ session, 3 sessions/ week for 4 weeks (a total of 12 training sessions).
The training includes 20 min of sling exercise training and 10 min treadmill training.
|
Active Comparator: Conventional training group
Participants will practice balance exercise, including sit-to-stand, forward reaching, postural training on the therapeutic ball, maintaining standing balance with eyes open and progress to eyes close, and tandem stance.
|
All participants will receive exercise training for 30 min/ session, 3 sessions/ week for 4 weeks (a total of 12 training sessions).
The training includes 20 min of balance exercise training and 10 min treadmill training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gait performance: change in gait speed
Time Frame: Change from baseline gait speed at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using GAITRite® system to evaluate gait speed in comfortable speed
|
Change from baseline gait speed at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Gait performance: change in stride length
Time Frame: Change from baseline stride length at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using GAITRite® system to evaluate stride length in comfortable speed
|
Change from baseline stride length at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Gait performance: change in single leg support time
Time Frame: Change from baseline single leg support time at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using GAITRite® system to evaluate single leg support time in comfortable speed
|
Change from baseline single leg support time at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Gait performance: change in temporal and spatial symmetry index
Time Frame: Change from baseline temporal and spatial symmetry index at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using GAITRite® system to evaluate temporal and spatial symmetry index in comfortable speed
|
Change from baseline temporal and spatial symmetry index at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Balance: change in movement velocity
Time Frame: Change from baseline movement velocity at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using Balance Master®: Limits of Stability test to assess movement velocity during moving center of pressure to the highlighted target.
|
Change from baseline movement velocity at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Balance: change in directional control
Time Frame: Change from baseline directional control at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using Balance Master®: Limits of Stability test to assess directional control during moving center of pressure to the highlighted target.
|
Change from baseline directional control at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Balance: change in maximal excursion
Time Frame: Change from baseline maximal excursion at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using Balance Master®: Limits of Stability test to assess maximal excursion during moving center of pressure to the highlighted target.
|
Change from baseline maximal excursion at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Balance: change in one leg stance
Time Frame: Change from baseline postural sway under one leg stance at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using Balance Master® to measure the sway under one leg standing
|
Change from baseline postural sway under one leg stance at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Balance: change in functional balance performance
Time Frame: Change from baseline BBS at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using Berg Balance Scale (BBS) to assess functional balance performance.
Berg Balance Scale is a 14-item scale which scoring 0-4 of each, ranges from 0 to 56, and higher score indicates better balance performance.
|
Change from baseline BBS at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Change in mobility performance
Time Frame: Change from baseline mobility performance at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using Timed up-and-go (TUG) test to assess mobility
|
Change from baseline mobility performance at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Change in trunk control
Time Frame: Change from baseline TIS at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using Trunk Impairment Scale (TIS) to assess ability of trunk control.
The trunk impairment scale ranges from 0 to 23, and a higher scoring indicates a better trunk control.
|
Change from baseline TIS at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Change in trunk muscle strength: trunk flexors
Time Frame: Change from baseline strength of trunk flexors at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using hand held dynamometer (Power Tract II) to measure muscle strength of trunk flexors
|
Change from baseline strength of trunk flexors at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Change in trunk muscle strength: trunk extensors
Time Frame: Change from baseline strength of trunk extensors at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using hand held dynamometer (Power Tract II) to measure muscle strength of trunk extensors
|
Change from baseline strength of trunk extensors at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Change in trunk muscle strength: trunk lateral flexors
Time Frame: Change from baseline strength of trunk lateral flexors at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Using hand held dynamometer (Power Tract II) to measure muscle strength of trunk lateral flexors
|
Change from baseline strength of trunk lateral flexors at 4 weeks and at 4 weeks after the intervention period (pre-, post-test and follow-up)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ray-Yau Wang, PhD, National Yang Ming Chiao Tung University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YM111016F
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Stroke
-
The University of Texas Health Science Center,...Recruiting
-
IRCCS San Raffaele RomaIRCCS Sacro Cuore Don Calabria di Negrar; Ospedale Riabilitativo di Alta Specializzazione... and other collaboratorsCompletedCardiovascular Diseases | Vascular Diseases | Cerebrovascular Disorders | Brain Diseases | Central Nervous System Diseases | Acute Stroke | Chronic Stroke | Severe Stroke | Mild StrokeItaly
-
University of Illinois at ChicagoNot yet recruiting
-
VA Office of Research and DevelopmentRecruitingChronic StrokeUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Chronic Stroke | Subacute StrokeThailand
-
University of WashingtonRecruitingStroke, Ischemic | Chronic StrokeUnited States
-
Ever Neuro Pharma GmbHVASCage GmbHTerminatedChronic Stroke | Subacute StrokeAustria
-
IRCCS San Raffaele RomaAzienda Ospedaliero, Universitaria Pisana; I.R.C.C.S. Fondazione Santa Lucia; Fondazione Don Carlo Gnocchi Onlus and other collaboratorsCompletedStroke | Acute Stroke | Chronic StrokeItaly
-
University of LahoreRecruitingChronic Hemorrhagic StrokePakistan
Clinical Trials on Sling exercise training
-
Norwegian University of Science and TechnologyNorwegian Fund for Postgraduate Training in PhysiotherapyCompleted
-
Cairo UniversityCompleted
-
Christiana Care Health ServicesTerminated
-
American Medical SystemsCompletedUrinary Incontinence, StressCanada, United States
-
University of AlbertaCompleted
-
University of AlbertaCompleted
-
Federal University of São PauloCompletedFemale Stress Urinary IncontinenceBrazil
-
Istanbul Physical Medicine Rehabilitation Training...CompletedRehabilitation | HemiplegiaTurkey
-
Stanford UniversityWithdrawn
-
University of British ColumbiaMichael Smith Foundation for Health ResearchCompleted